Overview
Buruli ulcer is a chronic, debilitating skin infection caused by Mycobacterium ulcerans, characterized by necrotic skin lesions and potential long-term disability 1.Diagnosis
Clinical presentation includes painless swelling, skin ulceration, and undermined edges 1.
Histopathology showing characteristic "necrotizing granulomas" with acid-fast bacilli (AFB) is crucial 1.
Polymerase chain reaction (PCR) targeting M. ulcerans specific sequences aids in definitive diagnosis 1.
Imaging (ultrasound, MRI) may help assess lesion extent and monitor treatment response 1.Management
First-line treatment involves a combination of antibiotics: rifampin and streptomycin, often supplemented with clarithromycin 1.
Surgical interventions such as debridement and skin grafting may be necessary for extensive lesions 1.
Multidrug therapy duration typically spans several months, guided by clinical and microbiological response 1.Special Populations
Pregnancy: Management strategies should prioritize safety; limited specific guidelines available, consult expert opinion 1.
Pediatrics: Early diagnosis and aggressive antibiotic therapy are crucial to prevent severe deformities 1.
Elderly: Consider comorbidities when selecting treatment; multidisciplinary care is recommended 1.
Comorbidities: Presence of other conditions may influence antibiotic choice and necessitate close monitoring 1.Key Recommendations
Utilize histopathology and PCR for definitive diagnosis of Buruli ulcer (Evidence: Strong 1).
Initiate treatment with a combination of rifampin and streptomycin, potentially adding clarithromycin for severe cases (Evidence: Moderate 1).
Incorporate surgical debridement for large or complicated ulcers to prevent deformity (Evidence: Expert opinion 1).References
1 Silva MT, Portaels F, Pedrosa J. Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control?. PLoS medicine 2007. link